• Health & Wellness

BronchiLIFTVITILIFT Baby DropsVITILIFT Kids SyrupGlutenBREAK Capsules PROBILIFT L DropsPROBILIFT D DropsPROBILIFT DailyPROBILIFT Acute

BRONCHILIFT

BronchiLIFT Cough & Cold is a traditional herbal mixture that primarily relieves a productive cough and symptoms associated with the common cold and flu.

What does BronchiLIFT Cough & Cold do?

  • Mucolytic: Dilutes and liquifies mucous
  • Spasmolytic: Relieves spasms or cramps in the bronchial muscles
  • Bronchodilator: Opens the respiratory airway for ease of breathing
  • Expectorant: Expels mucous from the airways
  • Antibacterial and Antifungal activities: Fights infection
  • Antioxidant properties

How to use BronchiLIFT Cough & Cold:

DOSAGE AND DIRECTIONS FOR USE:
CHILDREN AGES 6-12: 5 ML (ONE MEDICINE SPOON) TWICE DAILY
CHILDREN ABOVE 12 YEARS: 5 ML (ONE MEDICINE SPOON) THREE TIMES DAILY
ADULTS: 5 ML (ONE MEDICINE SPOON) THREE TIMES DAILY

Ingredients:
Active substances per 5 ml syrup:
Pelargonium S70 (Pelargonium sidoides DC.)     28,57 mg
Hedera helix L. (Ivy Leaf) extract                          35 mg

Inactive ingredients:
Citric acid, flavouring, glycerine, maltodextrin, microcrystalline cellulose, carmellose sodium and water.
Preservatives: Potassium sorbate (0,035 % m/v), sodium benzoate (0,045 % m/v).
Contains sweetener: sorbitol (2,5 g/5 ml).
Contains sweetener CSA 80 16,41 mg/5 ml (acesulfame potassium, sodium saccharin and
sodium cyclamate).

Alcohol, sugar, lactose and tartrazine free.

Professional Information & Patient Information Leaflet

Pdf Download

Shop now Read more

VITILIFT Baby Drops

The boost your little one needs

VitiLIFT is a multivitamin health supplement for the maintenance of good health and to support your child’s general wellbeing.

BABY DROPS

Provides your little one with essential vitamins needed for physical and mental growth and development:

  • Helps in the development and maintenance of bones and teeth.

  • Helps to metabolise carbohydrates, fats and proteins.

  • Contributes to the maintenance of eyesight, skin, membranes and immune function.

Alcohol, sugar, lactose and tartrazine free.
DOSAGE AND DIRECTIONS FOR USE:
Babies aged 0 to 6 months:0,6 ml daily
Babies aged 7 to 12 months:1 ml daily
Children aged 1 to 3 years:1 ml daily
Ingredients: Each 1 ml contains:
%DRI* (1-3 Years)%DRI* (4-8 Years)
Vitamin A
(Retinol)		1665 I.U.75 %100 %
Vitamin D3
(Cholecalciferol)		200 I.U.60 %100 %
Vitamin B1
(Thiamine)		0,3 mg90 %100 %
Vitamin B2
(Riboflavin)		0,4 mg80 %100 %
Vitamin B3
(Nicotinamide)		3,3 mg100 %83,33 %
Vitamin B6
(Pyridoxine)		0,167 mg100 %55,67 %
Vitamin C
(Ascorbic acid, calcium ascorbate)		50 mg75 %100 %

*DRI: Dietary Reference Intake

The other ingredients are: flavouring, glycerine, maltodextrin, microcrystalline cellulose, potassium bicarbonate, carmellose sodium and water.
Contains preservatives: potassium sorbate (0,035 % m/v) and sodium benzoate (0,045 % m/v).
Contains sorbitol (0,42 g/1 ml).
Contains sweetener CSA 80 2 mg/1 ml (acesulfame potassium, sodium cyclamate and sodium saccharin).

Professional Information & Patient Information Leaflet

Pdf Download

Read more Shop now

VITILIFT Kids Syrup

The boost your little one needs

VitiLIFT is a multivitamin health supplement for the maintenance of good health and to support your child’s general wellbeing.

KIDS SYRUP

Provides your little one with essential vitamins needed for physical and mental growth and development:

  • Helps to metabolise carbohydrates, fats and proteins.

  • Contributes to the development and maintenance of night vision.

  • Helps in the development and maintenance of bones, cartilage, teeth and gums.

  • Contributes to the maintenance of eyesight, skin, membranes and immune function.

  • Antioxidant benefit for the maintenance of good health provides protection against the damaging effects of free radicals in cells.

Alcohol, sugar, lactose and tartrazine free.
DOSAGE AND DIRECTIONS FOR USE:
CHILDREN AGED 1 TO 3 YEARS: 5 ML (ONE MEDICINE SPOON) DAILY
CHILDREN AGED 4 TO 8 YEARS: 10 ML (TWO MEDICINE SPOONS) DAILY

Ingredients: Each 5 ml contains:

%DRI* (1-3 YEARS) %DRI* (4-8 YEARS)
VITAMIN A
(RETINOL)		 999 I.U. 100 % 150 %
VITAMIN D3
(CHOLECALCIFEROL)		 160 I.U. 80 % 160 %
VITAMIN B1
(THIAMINE)		 0,5 MG 100 % 166,67 %
VITAMIN B2
(RIBOFLAVIN)		 0,5 MG 100 % 166,67 %
VITAMIN B3
(NICOTINAMIDE)		 6,0 MG 100 % 150 %
VITAMIN B6
(PYRIDOXINE)		 0,5 MG 100 % 166,67 %
VITAMIN B12
(CYANOCOBALAMIN)		 0,9 MCG 100 % 150 %
VITAMIN E
(TOCOPHEROL)		 6 I.U. 67,12 % 115,06 %
VITAMIN C
(ASCORBIC ACID)		 20 MG 133,33 % 160 %

Professional Information & Patient Information Leaflet

Pdf Download

Read more Shop now

GlutenBREAK Capsules

For gluten sensitivity | 30 Capsules

GLUTENBREAK is a probiotic supplement specifically formulated with 6 probiotic strains and Tolerase G® (prolyl-oligopeptidase), an enzyme that  breaks down proline-rich proteins like gluten that are difficult to digest1.

The poorly digested gluten fragments can cause an adverse response in some individuals, resulting in flatulence or bloating, abdominal discomfort, diarrhoea, constipation and allergic skin conditions2-3.

By supplementing your diet with GLUTENBREAK, you can assist the breakdown of hidden gluten in foods and relieve some of the digestive symptoms it may cause. The probiotic combination inside GLUTENBREAK may also assist in the breakdown of other common digestive irritants like lactose and other FODMAPs4, as well as support a healthy gut and immune system.

What does GLUTENBREAK do?

  • Digests gluten to reduce the symptoms of gluten sensitivity

  • Helps fight infections caused by harmful bacteria

  • Strengthens the immune system

  • Supports a healthy gut

Probiotics can assist in:

  • The breakdown of gut irritants like lactose and other FODMAPs4.

  • Minimising GI discomfort and bloating associated with IBS (irritable bowel syndrome), IBD (inflammatory bowel disease) & colitis (intestinal inflammation)5.

  • Reducing the risk and severity of diarrhoea and constipation6.

How much “HIDDEN” GLUTEN are you consuming?

Studies show that even when adopting a gluten-free diet, unintentional or “hidden” gluten can still find its way in. The average gluten intake while on a gluten-free diet is ∼500mg/day7-9.

Not all gluten is obvious. Sources of “hidden” gluten include chocolates, herbal teas, ice cream, rice mixes, sauces and soups8-11.
http://www2.ca.uky.edu/agc/pubs/FCS3/FCS3564/FCS3564.pdf

Resources:

  1. Konig et al. (2016). Aspergillus niger-derived enzyme AN-PEP efficiently degrades gluten in the stomach of gluten-sensitive subjects. Clinical Nutrition, 35(1), 152.
  2. Sapone, A. et al. (2012). Spectrum of gluten-related disorders: consensus on new nomenclature and classification. BMC Medicine, 10, 13.
  3. Fasano, A., Sapone, A., Zevallos, V., Schuppan, D. (2015). Nonceliac gluten sensitivity. Gastroenterology, 148, 1195–1204.
  4. Rossi, M., Corradini, C., Amaretti, A., Nicolini, M., Pompei, A., Zanoni, S., Matteuzzi, D. (2005). Fermentation of Fructooligosaccharides and Inulin by Bifidobacteria: a Comparative Study of Pure and Fecal Cultures, as well as support a healthy gut and immune system. Applied and Environmental Microbiology, 71(10), 6150–6158.
  5. Ringel, Y., Ringel-Kulka, T., Maier, D., Carroll, I., Galanko, J. A., Leyer, G., Palsson, O. S. (2011). Clinical trial: Probiotic Bacteria Lactobacillus acidophilus NCFM and Bifidobacterium lactis Bi-07 Versus Placebo for the Symptoms of Bloating in Patients with Functional Bowel Disorders – a Double-Blind Study. Journal of Clinical Gastroenterology, 45(6), 518–525.
  6. Sazawal, S., Hiremath, G., Dhingra, U., Malik, P., Deb, S, Black, R. E. (2006). Efficacy of probiotics in prevention of acute diarrhoea: a meta-analysis of masked, randomised, placebo-controlled trials. The Lancet Infectious Diseases, 6(6), 374 –382.
  7. Van Overbeek, F., et al. (1997). The daily gluten intake in relatives of patients with coeliac disease compared with that of the general Dutch population. European Journal of Gastroenterology and Hepatology, 9(11), 1097-1099.
  8. Hopman, E., et al. (2006). Nutritional management of the gluten-free diet in young people with celiac disease in The Netherlands. Journal of Pediatric Gastroenterology and Nutrition, 43(1), 102-108.
  9. Hopman, E., et al. (2008). Gluten tolerance in adult patients with celiac disease 20 years after diagnosis?, European Journal of Gastroenterology and Hepatology, 20(5), 423-449.
  10. Errichiello, S., et al. (2010). Celiac disease: predictors of compliance with a gluten-free diet in adolescents and young adults. Journal of Pediatric Gastroenterology and Nutrition, 50(1), 54-60.
  11. Lovik et al. (2017). Diet adherence and gluten exposure in coeliac disease and self-reported non-coeliac gluten sensitivity. Journal of Clinical Nutrition, 36, 275-280.

Professional Information & Patient Information Leaflet

Pdf Download

Read More Shop now

PROBILIFT L Drops

(For Lactose Intolerance)

6-Strain Probiotic + Lactase

Probiotics are beneficial bacteria essential for improving intestinal health.
ProbiLIFT L is a probiotic supplement specifically formulated with 6 probiotic strains and lactase.

What does ProbiLIFT L do?

  • Breaks down lactose to reduce the symptoms of lactose intolerance

  • Assists infants in digesting lactose, preventing flatulence, vomiting,
    diarrhoea, and long periods of restlessness and crying.

  • Fights the growth of harmful bacteria7

  • Supports the immune system8

  • Increases the levels of beneficial bacteria in the gut7

ProbiLIFT L can replace the good bacteria lost through:

  • Antibiotic treatment3

  • Diarrhoea & Constipation7,8

  • GI infection10

  • Old age6

  • Malnutrition

ProbiLIFT L can assist in:

  • Reducing the side effects of antibiotic treatment3

  • Prevention and treatment of allergic skin reactions and eczema9

  • Minimising GI discomfort and bloating associated with IBS (irritable bowel syndrome), IBD (inflammatory bowel disease) & colitis (intestinal inflammation)4,5

Why 6 strains?

The beneficial effects of probiotics are both strain-and dose-specific. A combination of various probiotic strains working together has been shown to be the most effective in the gut1. In addition, more significant results can be achieved with multiple strains in combination compared to single strain preparations2.

DOSAGE AND DIRECTIONS FOR USE:
Babies and children up to 12 years:
Use 1 ml with every feed or meal. Give 1 ml just before breastfeeding. Add 1 ml to the prepared formula feed.
Adults:
Add 1 ml to a lactose-containing foodstuff and consume immediately.

INGREDIENTS:  Active substances per 1 ml:
1 billion CFU* probiotics consisting of a blend of:
Bifidobacterium lactis BI-07® 200 million CFU
Bifidobacterium longum BI-05® 150 million CFU
Lactobacillus acidophilus La-14® 200 million CFU
Lactobacillus reuteri 1E1 150 million CFU
Lactobacillus rhamnosus Lr-32® 150 million CFU
Lactobacillus salivarius Ls-33® 150 million CFU

Tolerase® L (lactase)

1 500 ALU**/ml

*CFU – Colony Forming Units
** Acid Lactase Unit

Tolerase® L is a trademark of DSM.
Inactive Ingredients: Medium Chain Triglyceride (MCT) oil and silicon dioxide.

Resources:

  1. Timmerman, H. M., Koning, C. J., Mulder, L., Rombouts, F. M., Beynen, A. C. (2004). Monostrain, multistrain and multispecies probiotics: a comparison of functionality and efficacy. International Journal of Food Microbiology, 96(3), 219-233.
  2. Leyer, G. J., Li, S., Mubasher, M. E., Reifer, C., Arthur C. Ouwehand, A. C. (2009). Probiotic Effects on Cold and Influenza-Like Symptom Incidence and Duration in Children. Pediatrics, 124, 172-179.
  3. Kyne, L., Kelly, C. P. (2001). Recurrent Clostridium difficile diarrhoea. Gut, 49, 152–153.
  4. Ringel, Y., Ringel-Kulka, T., Maier, D., Carroll, I., Galanko, J. A., Leyer, G., Palsson, O. S. (2011). Clinical trial: Probiotic Bacteria Lactobacillus acidophilus NCFM and Bifidobacterium lactis Bi-07 Versus Placebo for the Symptoms of Bloating in Patients with Functional Bowel Disorders – a Double-Blind Study. Journal of Clinical Gastroenterology, 45(6), 518–525.
  5. Van der Kleij, H., O’Mahony, C., Shanahan, F., O’Mahony, L., Bienenstock, J. (2008). Protective effects of Lactobacillus reuteri and Bifidobacterium infantis in murine models for colitis do not involve the vagus nerve. American Journal of Physiology- Regulatory, Integrative & Comparative Physiology, 295, 1131–1137.
  6. Biagi, E., Candela, M., Fairweather-Tait, S., (2012). Aging of the human metaorganism: the microbial counterpart. Age, 34, 247–267.
  7. Sazawal, S., Hiremath, G., Dhingra, U., Malik, P., Deb, S, Black, R. E. (2006). Efficacy of probiotics in prevention of acute diarrhoea: a meta-analysis of masked, randomised, placebo-controlled trials. The Lancet Infectious Diseases, 6(6), 374 –382.
  8. Guandalini, S. (2006). Probiotics for children: use in diarrhea. Journal of Clinical Gastroenterology, 40(3), 244–248.
  9. Rautava, S., Kalliomaki, M., Isolauri, E. (2005). New therapeutic strategy for combating the increasing burden of allergic disease: probiotics: a Nutrition, Allergy, Mucosal Immunology and Intestinal Microbiota (NAMI) Research Group report. Journal of Allergy & Clinical Immunology, 116(1, 31–37.
  10. Fooks, L. J., Fuller, R., Gibson, G. R. (1999). Prebiotics, probiotics and human gut microbiology. International Dairy Journal, 9, 53-61.
  11. Binns, N. (2013.) Probiotics, Prebiotics and the Gut Microbiota. ILSI Europe Concise Monograph Series.

Professional Information & Patient Information Leaflet

Pdf Download

Read more

PROBILIFT D Drops

6-Strain Probiotic + Vitamin D3

Probiotics are beneficial bacteria essential for improving intestinal health. The microflora of newborn babies is underdeveloped, making them more susceptible to opportunistic gut conditions1. ProbiLIFT D is a probiotic supplement specifically formulated with 6 probiotic strains and vitamin D.

By supplementing your baby’s diet with ProbiLIFT D, you can strengthen the barrier effect in the intestines to keep them healthy2. Probiotics can increase the levels of beneficial bacteria in the gut, creating an environment that is unfavourable to the growth of harmful bacteria.

By introducing live probiotic cultures to the intestinal tract, the beneficial gut flora populations are increased and transitory flora, including pathogenic or bad bacteria, are not able to colonise within the intestines3. The addition of vitamin D may help with the development of healthy bones and teeth and may contribute to the normal function of the immune system.

What does ProbiLIFT D do?

  • Fights the growth of harmful bacteria

  • Supports the immune system

  • Assists in the development of healthy bones & teeth

ProbiLIFT D can replace the good bacteria lost through:

  • Antibiotic treatment4

  • Diarrhoea & Constipation5,6

  • GI infection3

  • Malnutrition

Probiotics can assist in:

  • Reducing the side effects of antibiotic treatment4.

  • Minimising GI discomfort and bloating associated with IBS (irritable bowel syndrome), IBD (inflammatory bowel disease) & colitis (intestinal inflammation)9,10.

  • Prevention and treatment of allergic skin reactions and eczema11.

Why 6 strains?

The beneficial effects of probiotics are both strain-and dose-specific. A combination of various probiotic strains working together has been shown to be the most effective in the gut7. In addition, more significant results can be achieved with multiple strains in combination compared to single strain preparations8.

DOSAGE AND DIRECTIONS FOR USE:
Children < 2 years 1 ml daily

INGREDIENTS:  Active substances per 1 ml:
1 billion CFU* probiotics consisting of a blend of:
Bifidobacterium lactis BI-07® 200 million CFU
Bifidobacterium longum BI-05® 150 million CFU
Lactobacillus acidophilus La-14® 200 million CFU
Lactobacillus reuteri 1E1 150 million CFU
Lactobacillus rhamnosus Lr-32® 150 million CFU
Lactobacillus salivarius Ls-33® 150 million CFU
Vitamin D3 (as cholecalciferol) 400 IU

*CFU – Colony Forming Units

Inactive Ingredients:
Medium Chain Triglyceride (MCT) oil and silicon dioxide.

Resources:

  1. Binns, N. (2013) Probiotics, Prebiotics and the Gut Microbiota. ILSI Europe Concise Monograph Series.
  2. Lutgendorff, F., Akkermans, L. M., Söderholm, J. D. (2008). The role of microbiota and probiotics in stress-induced gastrointestinal damage. Current Molecular Medicine, 8, 282-98.
  3. Fooks, L. J., Fuller, R., Gibson, G. R. (1999). Prebiotics, probiotics and human gut microbiology. International Dairy Journal, 9, 53-61.
  4. Kyne, L., Kelly, C. P. (2001). Recurrent Clostridium difficile diarrhoea. Gut, 49, 152–153.
  5. Sazawal, S., Hiremath, G., Dhingra, U., Malik, P., Deb, S, Black, R. E. (2006). Efficacy of probiotics in prevention of acute diarrhoea: a meta-analysis of masked, randomised, placebo-controlled trials. The Lancet Infectious Diseases, 6(6), 374 –382.
  6. Guandalini, S. (2006). Probiotics for children: use in diarrhea. Journal of Clinical Gastroenterology, 40(3), 244–248.
  7. Timmerman, H. M., Koning, C. J., Mulder, L., Rombouts, F. M., Beynen, A. C. (2004). Monostrain, multistrain and multispecies probiotics: a comparison of functionality and efficacy. International Journal of Food Microbiology, 96(3), 219-233.
  8. Leyer, G. J., Li, S., Mubasher, M. E., Reifer, C., Arthur C. Ouwehand, A. C. (2009). Probiotic Effects on Cold and Influenza-Like Symptom Incidence and Duration in Children. Pediatrics, 124, 172-179.
  9. Ringel, Y., Ringel-Kulka, T., Maier, D., Carroll, I., Galanko, J. A., Leyer, G., Palsson, O. S. (2011). Clinical trial: Probiotic Bacteria Lactobacillus acidophilus NCFM and Bifidobacterium lactis Bi-07 Versus Placebo for the Symptoms of Bloating in Patients with Functional Bowel Disorders – a Double-Blind Study. Journal of Clinical Gastroenterology, 45(6), 518–525.
  10. Van der Kleij, H., O’Mahony, C., Shanahan, F., O’Mahony, L., Bienenstock, J. (2008). Protective effects of Lactobacillus reuteri and Bifidobacterium infantis in murine models for colitis do not involve the vagus nerve. American Journal of Physiology- Regulatory, Integrative & Comparative Physiology, 295, 1131–1137.
  11. Rautava, S., Kalliomaki, M., Isolauri, E. (2005). New therapeutic strategy for combating the increasing burden of allergic disease: probiotics: a Nutrition, Allergy, Mucosal Immunology and Intestinal Microbiota (NAMI) Research Group report. Journal of Allergy & Clinical Immunology, 116(1, 31–37.

Professional Information & Patient Information Leaflet

Pdf Download

Read more Shop now

PROBILIFT Daily

6-Strain Probiotic for Digestive Health

Probiotics are beneficial bacteria essential for improving intestinal health. Certain medication or disease states can affect microflora and therefore increase the risk and susceptibility of gut infections1. ProbiLIFT Capsules are probiotic supplements specially formulated with 6 probiotic strains. By supplementing your diet with Probilift Capsules, you can strengthen your barrier effect to keep you healthy2.
Probiotics can increase the levels of beneficial bacteria in the gut, creating an environment that is unfavourable to the growth of harmful bacteria. By introducing live probiotic cultures to the intestinal tract, the beneficial gut flora populations are increased and transitory flora, including pathogenic or bad bacteria, are not able to colonise within the intestines2.

What do ProbiLIFT Capsules do?

  • Fights the growth of harmful bacteria

  • Supports the immune system

  • Supports a healthy gut

ProbiLIFT Capsules can replace the good bacteria lost through:

  • Antibiotic treatment3

  • Diarrhoea & Constipation4,5

  • GI infection2

  • Old Age11

  • Malnutrition

Probiotics can assist in:

  • Reducing the side effects of antibiotic treatment3

  • Minimising GI discomfort and bloating associated with IBS (irritable bowel syndrome), IBD (inflammatory bowel disease) & colitis (intestinal inflammation)8,9

  • Prevention and treatment of allergic skin reactions and eczema10

Why 6 strains?

The beneficial effects of probiotics are both strain- and dose-specific. A combination of various probiotic strains working together has been shown to be the most effective
in the gut6. In addition, more significant results can be achieved with multiple strains in combination compared to single strain preparations7.

DOSAGE AND DIRECTIONS FOR USE:
Adults:  One capsule daily

Ingredients:
Active substances per capsule:
1 billion CFU* probiotics consisting of a blend of:
Bifidobacterium lactis BI-07® 200 million CFU
Bifidobacterium longum BI-05® 150 million CFU
Lactobacillus acidophilus La-14® 200 million CFU
Lactobacillus reuteri 1E1 150 million CFU
Lactobacillus rhamnosus Lr-32® 150 million CFU
Lactobacillus salivarius Ls-33® 150 million CFU

*CFU – Colony Forming Units
Inactive Ingredients:
Medium Chain Triglyceride (MCT) oil and silicon dioxide.

Resources:

  1. Binns, N. (2013) Probiotics, Prebiotics and the Gut Microbiota. ILSI Europe Concise Monograph Series.
  2. Fooks, L. J., Fuller, R., Gibson, G. R. (1999). Prebiotics, probiotics and human gut microbiology. International Dairy Journal, 9, 53-61.
  3. Kyne, L., Kelly, C. P. (2001). Recurrent Clostridium difficile diarrhoea. Gut, 49, 152–153.
  4. Sazawal, S., Hiremath, G., Dhingra, U., Malik, P., Deb, S, Black, R. E. (2006). Efficacy of probiotics in prevention of acute diarrhoea: a meta-analysis of masked, randomised, placebo-controlled trials. The Lancet Infectious Diseases, 6(6), 374 –382.
  5. Guandalini, S. (2006). Probiotics for children: use in diarrhea. Journal of Clinical Gastroenterology, 40(3), 244–248.
  6. Timmerman, H. M., Koning, C. J., Mulder, L., Rombouts, F. M., Beynen, A. C. (2004). Monostrain, multistrain and multispecies probiotics: a comparison of functionality and efficacy. International Journal of Food Microbiology, 96(3), 219-233.
  7. Leyer, G. J., Li, S., Mubasher, M. E., Reifer, C., Arthur C. Ouwehand, A. C. (2009). Probiotic Effects on Cold and Influenza-Like Symptom Incidence and Duration in Children. Pediatrics, 124, 172-179.
  8. Ringel, Y., Ringel-Kulka, T., Maier, D., Carroll, I., Galanko, J. A., Leyer, G., Palsson, O. S. (2011). Clinical trial: Probiotic Bacteria Lactobacillus acidophilus NCFM and Bifidobacterium lactis Bi-07 Versus Placebo for the Symptoms of Bloating in Patients with Functional Bowel Disorders – a Double-Blind Study. Journal of Clinical Gastroenterology, 45(6), 518–525.
  9. Van der Kleij, H., O’Mahony, C., Shanahan, F., O’Mahony, L., Bienenstock, J. (2008). Protective effects of Lactobacillus reuteri and Bifidobacterium infantis in murine models for colitis do not involve the vagus nerve. American Journal of Physiology- Regulatory, Integrative & Comparative Physiology, 295, 1131–1137.
  10. Rautava, S., Kalliomaki, M., Isolauri, E. (2005). New therapeutic strategy for combating the increasing burden of allergic disease: probiotics: a Nutrition, Allergy, Mucosal Immunology and Intestinal Microbiota (NAMI) Research Group report. Journal of Allergy & Clinical Immunology, 116(1, 31–37.
  11. Biagi, E., Candela, M., Fairweather-Tait, S., (2012). Aging of the human metaorganism: the microbial counterpart. Age, 34, 247–267.

Professional Information & Patient Information Leaflet

Pdf Download

Read more Shop now

PROBILIFT Acute

6-Strain Probiotic for Digestive Health

Probiotics are beneficial bacteria essential for improving intestinal health. Certain medication or disease states can affect microflora and therefore increase the risk and susceptibility of gut infections1. ProbiLIFT Capsules are probiotic supplements specially formulated with 6 probiotic strains. By supplementing your diet with Probilift Capsules, you can strengthen your barrier effect to keep you healthy2.
Probiotics can increase the levels of beneficial bacteria in the gut, creating an environment that is unfavourable to the growth of harmful bacteria. By introducing live probiotic cultures to the intestinal tract, the beneficial gut flora populations are increased and transitory flora, including pathogenic or bad bacteria, are not able to colonise within the intestines2.

What do ProbiLIFT Capsules do?

  • Fights the growth of harmful bacteria

  • Supports the immune system

  • Supports a healthy gut

ProbiLIFT Capsules can replace the good bacteria lost through:

  • Antibiotic treatment3

  • Diarrhoea & Constipation4,5

  • GI infection2

  • Old Age11

  • Malnutrition

Probiotics can assist in:

  • Reducing the side effects of antibiotic treatment3

  • Minimising GI discomfort and bloating associated with IBS (irritable bowel syndrome), IBD (inflammatory bowel disease) & colitis (intestinal inflammation)8,9

  • Prevention and treatment of allergic skin reactions and eczema10

Why 6 strains?

The beneficial effects of probiotics are both strain- and dose-specific. A combination of various probiotic strains working together has been shown to be the most effective
in the gut6. In addition, more significant results can be achieved with multiple strains in combination compared to single strain preparations7.

DOSAGE AND DIRECTIONS FOR USE:
Adults:  One capsule daily

Ingredients:
Active substances per capsule:
1 billion CFU* probiotics consisting of a blend of:
Bifidobacterium lactis BI-07® 200 million CFU
Bifidobacterium longum BI-05® 150 million CFU
Lactobacillus acidophilus La-14® 200 million CFU
Lactobacillus reuteri 1E1 150 million CFU
Lactobacillus rhamnosus Lr-32® 150 million CFU
Lactobacillus salivarius Ls-33® 150 million CFU

*CFU – Colony Forming Units
Inactive Ingredients:
Medium Chain Triglyceride (MCT) oil and silicon dioxide.

Resources:

  1. Binns, N. (2013) Probiotics, Prebiotics and the Gut Microbiota. ILSI Europe Concise Monograph Series.
  2. Fooks, L. J., Fuller, R., Gibson, G. R. (1999). Prebiotics, probiotics and human gut microbiology. International Dairy Journal, 9, 53-61.
  3. Kyne, L., Kelly, C. P. (2001). Recurrent Clostridium difficile diarrhoea. Gut, 49, 152–153.
  4. Sazawal, S., Hiremath, G., Dhingra, U., Malik, P., Deb, S, Black, R. E. (2006). Efficacy of probiotics in prevention of acute diarrhoea: a meta-analysis of masked, randomised, placebo-controlled trials. The Lancet Infectious Diseases, 6(6), 374 –382.
  5. Guandalini, S. (2006). Probiotics for children: use in diarrhea. Journal of Clinical Gastroenterology, 40(3), 244–248.
  6. Timmerman, H. M., Koning, C. J., Mulder, L., Rombouts, F. M., Beynen, A. C. (2004). Monostrain, multistrain and multispecies probiotics: a comparison of functionality and efficacy. International Journal of Food Microbiology, 96(3), 219-233.
  7. Leyer, G. J., Li, S., Mubasher, M. E., Reifer, C., Arthur C. Ouwehand, A. C. (2009). Probiotic Effects on Cold and Influenza-Like Symptom Incidence and Duration in Children. Pediatrics, 124, 172-179.
  8. Ringel, Y., Ringel-Kulka, T., Maier, D., Carroll, I., Galanko, J. A., Leyer, G., Palsson, O. S. (2011). Clinical trial: Probiotic Bacteria Lactobacillus acidophilus NCFM and Bifidobacterium lactis Bi-07 Versus Placebo for the Symptoms of Bloating in Patients with Functional Bowel Disorders – a Double-Blind Study. Journal of Clinical Gastroenterology, 45(6), 518–525.
  9. Van der Kleij, H., O’Mahony, C., Shanahan, F., O’Mahony, L., Bienenstock, J. (2008). Protective effects of Lactobacillus reuteri and Bifidobacterium infantis in murine models for colitis do not involve the vagus nerve. American Journal of Physiology- Regulatory, Integrative & Comparative Physiology, 295, 1131–1137.
  10. Rautava, S., Kalliomaki, M., Isolauri, E. (2005). New therapeutic strategy for combating the increasing burden of allergic disease: probiotics: a Nutrition, Allergy, Mucosal Immunology and Intestinal Microbiota (NAMI) Research Group report. Journal of Allergy & Clinical Immunology, 116(1), 31–37.
  11. Biagi, E., Candela, M., Fairweather-Tait, S., (2012). Aging of the human metaorganism: the microbial counterpart. Age, 34, 247–267.

Professional Information & Patient Information Leaflet

Pdf Download

Read more Shop now